Orthofix Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	62.86	83.24	33.11	50.7	87.85	96.29
Cash & Short-Term Investments	62.86	83.24	33.11	50.7	87.85	96.29
Cash Growth	109.16%	151.42%	-34.70%	-42.29%	-8.77%	38.11%
Receivables	130.81	134.71	128.1	82.86	78.56	72.42
Inventory	174.04	189.45	222.17	100.15	82.97	84.64
Prepaid Expenses	23.37	23.38	32.42	22.28	20.14	16.5
Restricted Cash	3.09	2.5	4.65	-	-	0.53
Total Current Assets	394.17	433.29	420.44	255.99	269.52	270.38
Property, Plant & Equipment	153.98	157.04	178.93	65.02	62.41	68.45
Long-Term Investments	-	-	6.26	6.08	5.41	5
Goodwill	194.93	194.93	194.93	71.32	71.32	84.02
Other Intangible Assets	75.64	98.8	117.49	47.39	52.67	60.52
Long-Term Accounts Receivable	-	-	-	1.1	1.4	2
Long-Term Deferred Tax Assets	-	1.54	2.08	1.47	-	25.04
Long-Term Deferred Charges	-	1.1	1.9	0.7	1	1.4
Other Long-Term Assets	13.89	6.59	3.28	2.42	5.75	1.89
Total Assets	832.61	893.29	925.32	458.63	476.62	525.86
Accounts Payable	50.46	48.8	58.36	27.6	26.46	23.12
Accrued Expenses	-	98.66	93.28	49.1	49.94	48.71
Current Portion of Long-Term Debt	-	-	1.25	-	-	-
Current Portion of Leases	3.97	4.78	4.18	2.29	4.42	2.6
Current Unearned Revenue	-	-	-	-	4.79	9.83
Other Current Liabilities	105.42	16.39	8.15	4.63	20.22	19.63
Total Current Liabilities	159.85	168.63	165.22	83.62	105.83	103.9
Long-Term Debt	157.22	157.02	93.11	-	-	-
Long-Term Leases	43.29	31.92	35.66	24.62	21.33	25.28
Long-Term Unearned Revenue	-	-	-	-	-	4.02
Long-Term Deferred Tax Liabilities	-	5.64	4.17	1.26	1.08	-
Other Long-Term Liabilities	29.76	26.97	28.43	12.27	11.45	35.8
Total Liabilities	390.12	390.17	326.59	121.77	139.69	169
Common Stock	3.95	3.85	3.72	2.02	1.98	1.94
Additional Paid-In Capital	804.01	779.72	746.45	334.97	313.95	292.29
Retained Earnings	-366.11	-276.14	-150.14	1.25	21	59.38
Comprehensive Income & Other	0.63	-4.3	-1.29	-1.38	-	3.25
Shareholders' Equity	442.49	503.12	598.73	336.86	336.93	356.86
Total Liabilities & Equity	832.61	893.29	925.32	458.63	476.62	525.86
Total Debt	204.48	193.71	134.2	26.91	25.76	27.89
Net Cash (Debt)	-141.62	-110.47	-101.09	23.8	62.09	68.41
Net Cash Growth	-	-	-	-61.68%	-9.23%	59.87%
Net Cash Per Share	-3.61	-2.90	-2.75	1.19	3.15	3.53
Filing Date Shares Outstanding	39.6	39.02	37.41	36.46	19.85	19.51
Total Common Shares Outstanding	39.52	38.49	37.17	20.16	19.84	19.42
Working Capital	234.32	264.66	255.22	172.37	163.69	166.48
Book Value Per Share	11.20	13.07	16.11	16.71	16.99	18.37
Tangible Book Value	171.91	209.39	286.31	218.16	212.95	212.33
Tangible Book Value Per Share	4.35	5.44	7.70	10.82	10.74	10.93
Buildings	-	3.87	4.1	3.87	3.93	4.1
Machinery	-	262.7	235.45	148.88	159.1	151.44
Construction In Progress	-	22.69	41.75	4.52	2.6	1.63

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q